Human hantavirus infections can cause hemorrhagic fever with renal syndrome (HFRS), major signs of the disease being thrombocytopenia and transient kidney dysfunction. By a comprehensive and longitudinal study of circulating B cells, we demonstrate that these two pathologies associate with distinct effects on the humoral immune system during HFRS. Low thrombocyte counts strongly associated with an abnormal frequency of plasmablasts in circulation, whereas kidney dysfunction was indicative of an accumulation of CD27 -B cells and plasmablasts. Finally, we provide evidence that high levels of extracellular ATP in circulation during HFRS correlates with shedding of surface CD27 on B cells via a metallomatrix proteinase-8-mediated mechanism. Since extracellular ATP is known to regulate kidney function, our study reveals a link between kidney dysfunction and the generation of CD27 -IgD -B cells, and a potential molecular target for treatment of the symptomatic phase of HFRS. Dobrava, Seol and Puumala (PUUV) strains, where PUUV is endemic to Scandinavia. To date, no efficacious treatment or vaccination regimen exists to protect against severe hantavirus infections.
Introduction
Hantaviruses can cause two major forms of human disease; hantavirus cardiopulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Both of these diseases are characterized by endothelial cell dysfunction, vascular leakage and thrombocytopenia (reviewed in (1)). Hantaviruses that cause HPS include the Andes and Sin Nombre strains in North and South America. During HPS, the hantavirus infection causes severe vascular leakage in the lung and up to 40% of patients die (2). While lung-pathogenesis has also been described for HFRS and the symptoms can be severe, strain-dependent mortality rates for HFRS can be as low as 0.4% (2) (3) (4) . Hantavirus strains that cause HFRS includes Hantaan, mononuclear cells (PBMCs) and plasma/serum samples from twenty-six patients and seventeen age-and sex-matched healthy controls. Age distribution and general characteristics of the cohorts are shown in Table S1 . We collected and analyzed patient samples from acute (A), intermediate (I) and convalescent (C) phases of the disease (Figure 1A) . At the time of inclusion in the study, all patients had been diagnosed with acute PUUV infection by detection of IgM against the virus nucleocapsid protein, and we subsequently determined acute virus load in plasma by PCR ( Figure 1B) . Consistent with previous studies of HFRS patients, the disease had manifested with an acute but transient reduction of circulating thrombocytes ( Figure 1C ) and elevated levels of serum creatinine and C-reactive protein (CRP) (Figures 1D, E) . We further demonstrated that the thrombocytopenia in patients inversely correlated with viral load (r=-0.73; p<0.0001), but there was no significant correlation with the elevated levels of CRP and creatinine ( Figure 1F) . The lack of a correlation between thrombocytopenia and serum creatinine was in accordance with findings in a previous study of over 500 HFRS patients in Finland (22) . Collectively, these data confirmed a potential of longitudinal studies of HFRS to reveal whether thrombocytopenia or kidney dysfunction may differentially affect the humoral immune response to hantavirus infection.
Thrombocytopenia correlates with elevated levels of plasmablasts and plasma cells during HFRS. A transient elevation in the frequency of CD19 + CD38 + CD20 -PBs/PCs in circulation was detected during the acute phase (Gating strategy in Figure S1 ). Strikingly, several of the HFRS patients showed an extreme elevation of the frequency of PBs/PCs (comprising up to 80% of all circulating CD19 + B cells) (Figure 2A) . A similar extensive elevation of PB frequency had been reported to occur during HPS (14) . Surface expression of HLA-DR was reduced on recently formed (HLA-DR high Ki67 + ) PB during acute infection compared to convalescent phase and healthy controls (A vs C: p=0.0013; A vs. H p<0.0001), whereas surface expression of CD38 was increased at the same time points (A vs. C: p=0.0047; A vs. H: p=0.0024) ( Figure 2B ). In addition, the frequency of CCR10 + PBs was significantly increased during acute disease (A vs. C: p=0.0020; A vs. H: p=0.032) ( Figure   2B ). Since CCR10 expression is a common feature of IgA producing PBs that originate from mucosal immune responses (24, 25) , this is in line with PUUV infection to trigger development of . The fraction of PBs in patients that had upregulated CD138 in the acute phase was increased, as compared with the convalescent phase ( Figure   2C ). Consistent with the reduced HLA-DR on PBs, this demonstrated that hantavirus infection had led an increased frequency of B cells undergoing terminal differentiation to PB and subsequently to mature PCs (25, 27) . To better understand what drives the generation of PBs/PCs in circulation, we analyzed whether the observed PB-frequencies correlated with thrombocyte number and/or creatinine levels ( Figure 2D ). These analyses demonstrated a strong inverse correlation between thrombocyte numbers and both the frequency of PBs/PCs (r=-0.74; p<0.0001) and expression of CD138 on PBs (r=-0.50; p=0.012). As expected, we also found a strong correlation between the frequency of PBs/PCs and expression of the maturation marker CD138 on these cells during acute HFRS (r=0.64; p<0.001). Hence, both increased numbers and maturation status of PBs/PCs associated with the levels of thrombocytopenia but not with creatinine levels in the same patients.
Thrombocytes are a major source of the chemokine CXCL12 (28), which is critically involved in PB migration (29). Since Puumala virus infection can induce thrombocyte activation (30) and elevated levels of CXCL12 were detected during both PUUV-induced HFRS and Andes virus-induced HPS (31), we hypothesized that the infection may have mobilized both active and resting PBs/PCs into circulation. Therefore, we assessed the levels of proliferating PBs (Ki67 + ) and non-proliferating (Ki67 -) PBs/PCs in circulation ( Figure 2E ).
Consistent with an acute and antigen-driven B cell response, the majority of PBs in circulation during acute HFRS were Ki67 + . However, the absolute numbers of Ki67cells were also significantly elevated during the acute phase ( Figure 2E ). Although we could not decipher whether this was a direct effect of the thrombocytopenia, our data suggested that an influx of both recently activated PBs/PCs and previously formed PBs/PCs had contributed to the total levels of PBs/PCs in circulation during HFRS.
Thrombocytopenia is associated with decreased nucleocapsid-binding IgG during acute infection. To understand whether thrombocytopenia or kidney dysfunction could affect development of antiviral humoral immunity, we characterized the quantity and quality of antiviral antibodies in longitudinal plasma samples of patients with HFRS. We found that total circulating IgG, as well as albumin, was reduced during the acute phase of disease, but these values had normalized at the convalescent phase ( Figure S2A ). The reduction of albumin and IgG in circulation most likely reflected increased vascular and glomerular permeability, which was accompanied by clearance of albumin and IgG from the vascular to interstitial space and into urine (32, 33) . Subsequently, we assessed binding properties of plasma antibodies to the highly expressed nucleocapsid (N) protein and to the viral spike protein Gn of PUUV and found that both N-and Gn-binding IgG had been elicited in all patients during acute HFRS and that the overall PUUV-binding-potential had increased over time (N; p=0.0017, Gn; p=0.045) ( Figure 3A ). We found that the amount of N-and Gnbinding IgG between acute and convalescent phase of HFRS inversely correlated with thrombocyte numbers in patients (r=-0.50; p=0.016 and r=-0.45; p=0.032, respectively) ( Figure 3B ). In contrast, patients where thrombocyte numbers had remained high during the acute phase of disease had N-binding IgG with increased binding capacity in circulation (r=0.54; p=0.0076). Normalization of N-and Gn-binding IgG with total IgG levels showed High creatinine levels are correlated with longitudinal qualitative development of neutralizing antibodies. To assess the quality of the antiviral humoral immune response in patients, we determined the capacity of plasma antibodies to inhibit in vitro infection of target cells with "wild type" Kazan-strain PUUV. We found that potent neutralizing antibodies were present in plasma from all patients at the time points tested. In this assay, 50% inhibition was reached at reciprocal plasma dilution between 10 3 and 10 5 (EC50, Figure 3C ). This assay quantified total levels of virus RNA in infected cultures and it was possible that our results had been affected by differential capacity of virus quasi-species to replicate in the target cells, as previously shown (34). To reduce potential confounding factors, we subsequently assessed the capacity of plasma from HFRS patients to inhibit infection of target cells by a recombinant vesicular stomatitis virus that expressed the fluorophore mNeongreen and First, we determined that the absolute number of total B cells (CD19 + ) did not significantly change over the acute, intermediate or convalescent phases ( Figure 4C ). We then focused on the frequency distribution of naïve B cells (CD27 -IgD + ), unswitched memory B cells (CD27 + IgD + ), switched memory B cells (CD27 + IgD -) and double-negative B cells (CD27 -IgD -) (complete gating strategy in Figure S1 ). The relative frequency of switched memory and naïve B cells remained similar over time, as compared with uninfected controls ( Figure 4D ).
In contrast, the relative frequency of unswitched CD27 + IgD + memory B cells was significantly reduced during the acute and intermediate phases and the frequency of CD27 -IgD -B cells were significantly elevated throughout the disease ( Figure 4D ). In contrast to PBs, we found only a trend that the frequency of B cells with low CD27 surface expression and creatinine levels were associated (r=-0.37; p=0.08, Figure 4B ). However, the expression level of CD27 on PBs and the frequency of CD27 + CD20 + B cells showed a positive correlation (r=0.76; p<0.001, Figure 4B ). This suggested that the level of surface CD27 expression on PBs and B cells was linked. Even though the CD27 expression is likely not directly affected by creatinine levels, there may be a factor present in tissues or circulation during HFRS that could separately regulate both kidney function and creatinine levels, and CD27 expression levels on B cells. Increased creatinine levels (35) and accumulation of CD27 -IgD -B cells in circulation (18) have been reported to increase with age, but we could not find evidence that this had contributed to the decreased expression of CD27 on B cells ( Figure S3 ). We therefore proceeded to further characterize the CD27 -IgD -B cell population that had accumulated in circulation during HFRS. p=0.0015, HLA-DR; p=0.0002) ( Figure S4 ). Thus, the CD27 -IgD -B cells showed reduced activation potential as compared with CD27 + IgD -B cells. It was previously described that a subset of CD27 -IgD -B cells may comprise atypical B cells that are proposed to be exhausted during several chronic infectious or inflammatory diseases (38, 39) . Expression of the inhibitory Fc receptor-like protein 5 (Fcrl5) can be used to define atypical B cells within the CD27 -IgD -B cell population (40) and we proceeded to analyze CD27 -IgD -B cells during the acute phase of HFRS. We found that up to 60% of this B cell subset were positive for Fcrl5 expression ( Figure 5C ). To further verify that these cells were atypical B cells, we assessed whether Fcrl5 + or Fcrl5 -CD27 -IgD -B cells simultaneously expressed the integrin CD11c, the complement receptor 2 (CD21), the chemokine receptor CXCR3, and T-box transcription factor TBX21 (T-bet) (38, 41, 42) . Consistent with an "atypical" phenotype of Fcrl5 + cells, the frequency of CD11c, CXCR3 and T-bet were increased, whereas the frequency of CD21 expression was decreased in comparison with cells that were Fcrl5 -( Figure 5D ). We also found an increased frequency of Ki67 expression in Fcrl5 + CD27 -IgD -B cells ( Figure 5E ).
Thus, a large fraction of the atypical B cells had recently been proliferating, likely as a response to the hantavirus infection. In addition, these cells had increased expression of MHC class II (HLA-DR) in comparison with Fcrl5 -CD27 -IgD -B cells ( Figure 5F ). Since it was shown that atypical B cells downregulate transcription of CD27 (43), we assessed whether this was true also for the whole CD27 -IgD -B cell population. Although we found that transcriptional downregulation of CD27 had occurred in the heterogenous population of CD27 -IgD -B cells in both healthy controls and HFRS patients, the mRNA levels were generally higher than for naive CD27 -IgD + B cells in the same individuals ( Figure 5G ). This suggested that CD27 might be downregulated by an additional mechanism at the posttranscriptional level.
Extracellular ATP can induce shedding of CD27 from human B cells in vitro.
We first assessed whether altered CD27 expression could be induced by direct exposure of B cells to virus in vitro and found that neither short-or long-term exposure of PBMCs to virus reduced CD27 expression on isotype-switched IgD -B cells ( Figure 6A ). Previously, it had been shown that HFRS patients have elevated levels of soluble CD23 in circulation (44). Therefore, we simultaneously also measured CD23 expression on B cells and found this to be unaffected.
Consistent with shedding of membrane bound CD27, we found elevated levels of soluble found these to be elevated during acute HFRS ( Figure 6F ). Since ATP contribute to regulation of kidney function (51) and that the cause for kidney pathology during human PUUV infection remains unknown (23), we proceeded to investigate whether HFRS had led to elevated ATP-levels in fresh (unfrozen) plasma during acute phase of disease. First, we found that the average concentration of eATP in fresh plasma from 22 healthy individuals was 1.60 +/-0.58 μM. With this as baseline, we demonstrated that HFRS patients had elevated levels of eATP in plasma throughout the infection, including after the acute phase ( Figure 6G ). These data showed that the hantavirus infection, or the ensuing disease, had led to the presence of eATP in circulation, which persisted for more than a month in many of the patients. As expected from the extremely short half-life of eATP and decay due to freeze thawing, we could not reliably detect ATP in frozen plasma samples. However, we could assess levels of the ATP breakdown-products adenosine, inosine and uric acid, and use these as an indicator
for prior presence of extracellular ATP in frozen plasma samples from the 26 patients that this study was primarily based on (49). To correct for differences in baseline between patients we calculated a ratio based on the sum of breakdown products in plasma during acute infection divided by the sum of breakdown products in the paired convalescent plasma sample and found a correlation with acute creatinine levels in the same patients (r=0.47; p=0.024, Figure   6H ). Thus, our data demonstrated that hantavirus infection can induce an elevation of extracellular ATP in patients, and that this in turn can generate CD27 -IgD -B cells by MMP-8mediated shedding of CD27 from the cell surface of switched memory B cells.
DISCUSSION

By a comprehensive study of longitudinal PBMC and plasma samples from HFRS patients in
Sweden, we could demonstrate that the two hallmark symptoms of the hantavirus infection, thrombocytopenia and kidney dysfunction, were associated with altered quantity and quality of antiviral B cell responses, and that infection-induced eATP could have influenced the distribution of B cell subsets in circulation.
While a massive PB expansion in circulation has previously been shown during HPS and Dengue virus infection (14, 15) , our data reveal that this expansion may be linked to thrombocytopenia, a common symptom in both hantavirus and dengue virus infections. We
show that the expansion is, at least partially, due to mobilization of both activated and resting PBs/PCs into circulation. However, our data does not rule out that also a polyclonal expansion may have occurred, as previously suggested (21). Thrombocyte derived CXCL12, released upon thrombocyte activation, could potentially explain the increase of resting PBs/PCs in circulation, as CXCL12 is a well-known migratory chemokine for PBs/PCs. However, since thrombocytopenia in viral hemorrhagic fevers is associated with vascular leakage and diffusion of antibodies from circulation into tissues, the expanded and activated PB/PC population may also be a response to compensate for this loss. However, information on direct or indirect crosstalk between thrombocytes and the humoral immune system during infection is sparse (52) and, clearly, additional studies are required to dissect how and why the observed expansion occurs during both dengue virus and hantavirus infections.
A goal of our study was to evaluate whether thrombocytopenia or kidney dysfunction had affected the ability of patients to mount antiviral antibodies. Collectively, all patients had developed neutralizing antibodies to the virus, which demonstrates that neither of the symptoms had majorly affected patients' capacity to mount an efficient humoral immune response. However, we did observe a positive correlation between serum creatinine and a relative increase in neutralization potential over time in patients. Since we could not attribute this to a "lower" starting potential of neutralization during the acute phase, and as viral load in circulation was not linked to creatinine levels, we speculate that patients who manifest kidney dysfunction may have a more prominent and long-term inflammation due to the infection and that this could explain the long-term effect on neutralizing antibody responses. Due to the documented adjuvant effect of eATP (50), it is likely that the elevated levels of eATP had contributed to the induced anti-PUUV antibody response. In contrast, the thrombocytopenia was not linked to plasma neutralization potential but rather to an increase in overall PUUVbinding titers of plasma antibodies. While we did not specifically investigate the atypical B cell subset in this study, acute PUUV-induced HFRS leads to elevated levels of IFN-gamma in circulation (53). Therefore, the Fcrl5 + CD27 -IgDatypical B cell subset could have been generated by a similar B cell-receptor and IFN-gamma-dependent mechanism as was proposed for Plasmodium falciparum infection (54). Collectively, we found no indication that detection of CD27 -IgD -B cells, including the atypical B cell subset, had negatively impacted the qualitative neutralizing antibody response that had been elicited upon PUUV infection.
These data are similar to a recent study where an elevation of CD27 -IgD -B cells in circulation was associated with increased immunity to infection with Plasmodium falciparum (42).
An increased frequency of CD27 -IgD -B cells during kidney dysfunction had previously been described for SLE with nephritis (16). Here, we propose that the presence of eATP can contribute to the observed downregulation of CD27 on B cells. It is tempting to speculate that the hantavirus infection was the sole cause of the long-term elevation of extracellular ATP in patients, and that this could explain the long-term persistence of CD27 -IgD -B cells seen in our study. However, a lack of a pre-HFRS sample from patients did not allow us to investigate this notion further. It should also be noted that the eATP concentration at the local site of release is significantly higher than what can be measured in circulation, where it is rapidly degraded (55). It is therefore possible that cleavage of CD27 occurs when B cells pass through inflamed and infected tissues, rather than at all areas of the circulatory system. While inhibition of the ATP-responsive receptors P2 had little or no effect, MMP-8 had previously been implicated in shedding of CD27 from Waldenströms Macroglobulinemia cells (56).
Importantly, and similar to what has been proposed for other types of renal diseases (51, 57), studies to understand if antagonism of ATP signaling can reduce renal dysfunction during HFRS are warranted.
In summary, we show that both longitudinal development of neutralizing antiviral antibodies and the accumulation of CD27 -IgD -B cells, including Fcrl5+ atypical B cells, in circulation preferentially occur in patients with kidney dysfunction during acute HFRS. Our findings also pinpoint extracellular ATP as a factor that can act to generate CD27 -IgD -B cells by transcriptional downregulation of CD27 and to simultaneously affect kidney function (51).
Due to the role of extracellular ATP as mediator of systemic inflammation (58), we propose that elevated levels of CD27 -IgD -B cells in circulation are, at least partially, a reflection of a vigorous strong immune reaction with no detriment for the development of efficient antiviral immunity.
METHODS
Human Subjects
Peripheral blood mononuclear cells (PBMC), plasma, serum and clinical parameters were collected from patients during Puumala virus (PUUV) infection longitudinally. PBMC and plasma from healthy individuals were also collected, stored and used as a control group. B
cell and antibody characterization were generated from samples from 26 PUUV infected patients and 17 age and sex matched healthy volunteers except for data in Figure 4 Table S1 shows clinical characteristics of individuals studied.
Infection and shedding experiments where performed on PBMC isolated from buffy coats obtained from the blood bank within the University hospital. No information was available on sex or age from these donors.
Quantification of viral load
RNA was prepared from 140 µl serum or plasma with QiaAmp Viral RNA Kit (Qiagen)
according to the manufacturer's instructions. 60 µl RNA was eluted. RNA (5 µl) was added to KAPA SYBR Fast Universal One-Step qRT-PCR Kit (15 µl).
Step One Plus Real Time PCR System (Applied Biosystems) was used to perform the RT-qPCR. Analysis was performed with StepOne Plus Real-Time PCR System.
Flow cytometry
PBMCs were thawed and subsequently surface stained with fixable aqua dead cell stain kit 
Measurement of total and specific IgG
ELISA was used to assess plasma for quantity of total IgG as well as IgG binding PUUV proteins. Total IgG was assessed according to manufacturer's instructions: total IgG ELISA Mabtech. 200 ng/well of either N-protein or Gn-protein was coated on ELISA plates and plasma samples were tested 1:50 1:500 & 1:5000. As standard, one patient plasma was chosen to be on all ELISA plates with a serial dilution starting at a 1:50 dilution. Quantity in figures is shown as arbitrary units (AU) where AU 1 is equal to the amount in the reference plasma.
Detection and development were the same as the total IgG ELISA.
Expansion of PUUV Kazan and PBMC infection
Stocks of cell culture adapted PUUV Kazan-strain were obtained by infecting confluent Vero E6 cells in serum free DMEM supplemented with Hepes (20 mM), NaHCO 3 (0.75 g/l), 
Measurement of sCD27 and MMP-8
Quantity of sCD27 was determined using sCD27 ELISA kit and quantity of MMP-8 was determined using MMP-8 ELISA kit, both Invitrogen and used according manufacturer's instructions.
Measurement of ATP, inosine and uric acid
ATP was quantified in fresh plasma only, as it does not resist freeze-thawing. A firefly luciferase-based ATP determination kit (sensitive kit, Biaffin) was used according to manufacturer's instructions. An ATP standard curve was freshly prepared in 50 mM phosphate buffer (1 M phosphate buffer stock: 0.477 mol KH 2 PO 4 H 2 0; 0.523 mol Na 2 H 2 PO 4 *12H 2 0; pH 7.4/NaOH; ad 1 L). Blood was collected in EDTA tubes and the isolated plasma was diluted 1:50 in 50 mM phosphate buffer. As an additional control, spikes of known concentration of ATP (10 μM) were added to the diluted plasma samples to verify whether there were components in plasma that inhibit the assay reaction. Assay inhibition manifests as a quenched luminescence signal in spiked plasma with respect to spikes prepared in phosphate buffer and could hamper the quantification and the comparison of samples from different donors if not taken into account. The fraction of assay inhibition was calculated for every sample from the measured luminescence values using the formula: L spike in plasma -L plasma / L spike in buffer . The obtained factor gives the fraction of the assay reaction that is not inhibited, where 1 means that there is no assay inhibition. All plasma samples showed comparable assay inhibition after dilution, i.e. from 0.8 to 1.2 for ATP.
A standard curve of inosine or uric acid was prepared in 50 mM phosphate buffer. We found that EDTA from collection tubes interfered with the assay. Therefore, an equal amount of MgCl 2 was added to the plasma. ATP breakdown products were measured in both diluted
(1:100-1:800 in 50 mM phosphate buffer) and undiluted plasma samples. The assay was performed as described (61). Spikes of known concentration of inosine (12.5 μM) or uric acid (25 μM) were added to the diluted plasma samples to verify whether there were components in plasma that inhibit the assay reaction. The fraction of assay inhibition was calculated for every sample from the measured fluorescence values using the formula: F spike in plasma -F plasma / F spike in buffer . All plasma samples showed comparable assay inhibition after dilution, i.e. from 0.8 to 0.9 for inosine and 0.7 to 0.8 for uric acid.
The concentration of ATP and ATP breakdown products in plasma samples was extrapolated from standard curves. Standard curves were constructed in Microsoft Office Excel.
CD27 shedding by ATP
PBMCs from 7 healthy donors were incubated with ATP (Invitrogen, 6.7 mM), adenosine (Sigma, 6.7 mM), ATP and suramin (Sigma, 50 μM), ATP and MMP8 inhibitor (Merck, 10 µM) or control medium for 60 minutes at 37°C 5% CO 2 . Subsequently cells were analyzed by flow cytometry for changes in surface expression, analyzed with PCR for CD27 mRNA and supernatants were analyzed by ELISA for quantity of CD27. 
Statistical analysis
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